BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17971132)

  • 1. Correlation between atrial ZnT-1 expression and atrial fibrillation in humans: a pilot study.
    Etzion Y; Ganiel A; Beharier O; Shalev A; Novack V; Volvich L; Abrahamov D; Matsa M; Sahar G; Moran A; Katz A
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):157-64. PubMed ID: 17971132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between L-type calcium channels and ZnT-1, a new player in rate-dependent cardiac electrical remodeling.
    Beharier O; Etzion Y; Katz A; Friedman H; Tenbosh N; Zacharish S; Bereza S; Goshen U; Moran A
    Cell Calcium; 2007 Jul; 42(1):71-82. PubMed ID: 17196651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillation.
    Uemura N; Ohkusa T; Hamano K; Nakagome M; Hori H; Shimizu M; Matsuzaki M; Mochizuki S; Minamisawa S; Ishikawa Y
    Eur J Clin Invest; 2004 Nov; 34(11):723-30. PubMed ID: 15530144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
    Greiser M; Neuberger HR; Harks E; El-Armouche A; Boknik P; de Haan S; Verheyen F; Verheule S; Schmitz W; Ravens U; Nattel S; Allessie MA; Dobrev D; Schotten U
    J Mol Cell Cardiol; 2009 Mar; 46(3):385-94. PubMed ID: 19100271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial 11beta-hydroxysteroid dehydrogenase type 2 expression in rheumatic heart disease patients with or without atrial fibrillation].
    Pei DA; Li L; Xu ZY; Huang JY; Xu ZM; Wang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):385-9. PubMed ID: 19100026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation between angiotensin II receptors 1 and 2, and CYP11B2 and atrial structural remodeling in patients with atrial fibrillation].
    Wu YQ; Wang XD; Fang H; Wang YL; Zhang YC; Su LJ
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2281-4. PubMed ID: 18001553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation.
    Eiras S; Narolska NA; van Loon RB; Boontje NM; Zaremba R; Jimenez CR; Visser FC; Stooker W; van der Velden J; Stienen GJ
    J Mol Cell Cardiol; 2006 Sep; 41(3):467-77. PubMed ID: 16901501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation.
    Lezoualc'h F; Steplewski K; Sartiani L; Mugelli A; Fischmeister R; Bril A
    Biochem Biophys Res Commun; 2007 May; 357(1):218-24. PubMed ID: 17418812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the spatial distribution pattern of Cx40 gap junctions in the atria of patients with coronary heart disease.
    Zhou SH; He XZ; Liu QM; Du WH; Li XP; Zhou T; Tang JQ; Li RS
    Cardiol J; 2008; 15(1):50-6. PubMed ID: 18651385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mortalin in patients with chronic atrial fibrillation.
    Kirmanoglou K; Hannekum A; Schäfler AE
    Basic Res Cardiol; 2004 Nov; 99(6):404-8. PubMed ID: 15309412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of oxidative stress on atrial myocardium pathohistological and ultrastructural changes in atrial fibrillation: experiment with dogs].
    Li WM; Sheng L; Li Y; Yang BF; Gong YT; Xue HJ; Yu JB; Zhang L; Shan HB; Liu J
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):985-9. PubMed ID: 18756973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.
    Gramley F; Lorenzen J; Plisiene J; Rakauskas M; Benetis R; Schmid M; Autschbach R; Knackstedt C; Schimpf T; Mischke K; Gressner A; Hanrath P; Kelm M; Schauerte P
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1076-82. PubMed ID: 17655664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature.
    Barth AS; Merk S; Arnoldi E; Zwermann L; Kloos P; Gebauer M; Steinmeyer K; Bleich M; Kääb S; Hinterseer M; Kartmann H; Kreuzer E; Dugas M; Steinbeck G; Nabauer M
    Circ Res; 2005 May; 96(9):1022-9. PubMed ID: 15817885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troponin I isoform expression in human and experimental atrial fibrillation.
    Thijssen VL; Ausma J; Gorza L; van der Velden HM; Allessie MA; Van Gelder IC; Borgers M; van Eys GJ
    Circulation; 2004 Aug; 110(7):770-5. PubMed ID: 15289369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of biatrial pacing evaluated by means of signal-averaged P wave time-domain parameters. The significance of persistent atrial late potentials in right atrium during biatrial pacing.
    Kutarski A; Głowniak A; Szcześniak D; Ruciński P
    Cardiol J; 2008; 15(1):26-38. PubMed ID: 18651382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
    Tousoulis D; Zisimos K; Antoniades C; Stefanadi E; Siasos G; Tsioufis C; Papageorgiou N; Vavouranakis E; Vlachopoulos C; Stefanadis C
    Int J Cardiol; 2009 Aug; 136(3):258-62. PubMed ID: 18657327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.